These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 33319212)
1. Dual targeting of 3CL Rajpoot S; Alagumuthu M; Baig MS Curr Res Struct Biol; 2021; 3():9-18. PubMed ID: 33319212 [TBL] [Abstract][Full Text] [Related]
2. Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CL Saquib Q; Bakheit AH; Ahmed S; Ansari SM; Al-Salem AM; Al-Khedhairy AA Molecules; 2024 Feb; 29(5):. PubMed ID: 38474509 [TBL] [Abstract][Full Text] [Related]
3. Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme. Bahadur Gurung A; Ajmal Ali M; Lee J; Abul Farah M; Mashay Al-Anazi K J King Saud Univ Sci; 2020 Sep; 32(6):2845-2853. PubMed ID: 32837113 [TBL] [Abstract][Full Text] [Related]
4. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 replication and drug discovery. Nazir F; John Kombe Kombe A; Khalid Z; Bibi S; Zhang H; Wu S; Jin T Mol Cell Probes; 2024 Jul; 77():101973. PubMed ID: 39025272 [TBL] [Abstract][Full Text] [Related]
10. Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2. Kuo CJ; Chao TL; Kao HC; Tsai YM; Liu YK; Wang LH; Hsieh MC; Chang SY; Liang PH Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526482 [TBL] [Abstract][Full Text] [Related]
11. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. Báez-Santos YM; St John SE; Mesecar AD Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382 [TBL] [Abstract][Full Text] [Related]
12. Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design. Meyer-Almes FJ Comput Biol Chem; 2020 Oct; 88():107351. PubMed ID: 32769050 [TBL] [Abstract][Full Text] [Related]
13. "Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL Bhowmik D; Sharma RD; Prakash A; Kumar D J Mol Struct; 2021 Jun; 1233():130094. PubMed ID: 33612858 [TBL] [Abstract][Full Text] [Related]
14. [Bioactive compounds of Jingfang Granules against SARS-CoV-2 virus proteases 3CL Shang ZP; Yi Y; Yu R; Fan JJ; Huang YX; Qiao X; Ye M Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):907-919. PubMed ID: 36241233 [TBL] [Abstract][Full Text] [Related]
15. Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses. Wang R; Zhai G; Zhu G; Wang M; Gong X; Zhang W; Ge G; Chen H; Chen L Bioorg Chem; 2023 Jan; 130():106264. PubMed ID: 36395603 [TBL] [Abstract][Full Text] [Related]
17. Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2. da Cunha LNOL; Tizziani T; Souza GB; Moreira MA; Neto JSS; Dos Santos CVD; de Carvalho MG; Dalmarco EM; Turqueti LB; Scotti MT; Scotti L; de Assis FF; Braga AL; Sandjo LP Curr Med Chem; 2022; 29(14):2530-2564. PubMed ID: 34313197 [TBL] [Abstract][Full Text] [Related]
18. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. Park JY; Ko JA; Kim DW; Kim YM; Kwon HJ; Jeong HJ; Kim CY; Park KH; Lee WS; Ryu YB J Enzyme Inhib Med Chem; 2016; 31(1):23-30. PubMed ID: 25683083 [TBL] [Abstract][Full Text] [Related]
19. Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor. Ma C; Hu Y; Wang Y; Choza J; Wang J ACS Infect Dis; 2022 May; 8(5):1022-1030. PubMed ID: 35404564 [TBL] [Abstract][Full Text] [Related]
20. A Patent Review on SARS Coronavirus Papain-Like Protease (PL Brian Chia CS; Pheng Lim S ChemMedChem; 2023 Aug; 18(16):e202300216. PubMed ID: 37248169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]